doi:10.1002/ijgo.13102 Tang WZ, Cai QY, Huang KJ, et al
Autoridades como la FDA estadounidense y la EMA europea han aprobado su uso para adultos con obesidad, sobrepeso o comorbilidades asociadas
cracking down on sales of the drug to Americans?, Canadian Broadcasting Corporation (2023) Drug shortage report for Ozempic, Drug Shortages Canada (2024) Notice: Recommendations while Ozempic and other GLP-1 agonists are in shortage, Health Canada (2023) Ozempic, Cetaphil makers warn of impact from Trump tariffs, Bloomberg (2025) Doctor tied to thousands of Ozempic prescriptions in B.C
Edwin Guerrero is a board-certified Tijuana bariatric surgeon in Mexico, specializing in various weight loss surgery procedures
That comparison was unthinkable with any prior anti-obesity medication